Cadus Pharmaceutical Corp. (KDUS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cadus Pharmaceutical Corp. (KDUS)

KDUS 1.600

0.0%

Jul 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: John Metcalf who wrote (1028)	4/1/2003 12:08:54 AM
From: scaram(o)uche	of 1833

Who cares? Her background looks great, Glass just made a clean hand off, and there's a big hole up the middle. VPHM...... $20M just bought back $50 in debt. This for a company where, with partner Wyeth and at a MC (Friday) of $40M, is addressing a $3B market with multiple molecules (one of which is in clinicals). $1 will buy $5, and Cadus happens to have retained all of their $1s. So........... I presume that the answer is "no", but.... if "yes", mighty fine genetics.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next